Story to be published July 11, 2008.
Dr. Behlke, his team and collaborators are working on improving the delivery of Dicer-substrate siRNAs (DsiRNAs) in vitro and in vivo.
His work has helped establish siRNA technology as a viable tool for drug development.
Please see the article titled RNAi Researchers Galvanized by Advances: Technology’s Viability in Drug Development Is [...]
-
Featured Orgs
-
Connect
